secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001285550-23-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro reports Q4 2022 revenue $5.2M (+21% YoY); full-year revenue $20.6M (+26% YoY)
--------------------------------------------------------------------------------

- Q4 2022 revenue $5.2M, up 21% YoY; full-year revenue $20.6M, up 26% YoY (record).
- Biologics & drug delivery revenue $9.1M for 2022, up 34% YoY; over 50 partners.
- Gross margin 66% for 2022 vs 68% in 2021; Q4 gross margin 64% vs 77%.
- Cash & short-term investments $37.5M at Dec 31, 2022, down from $54.1M.
- Reiterates 2023 revenue guidance $25-27M, expecting >20% growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000019/0001285550-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000019/clpt-20230301.htm
  HTML page:      https://secwatch.observer/filing/0001285550-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer